Stability and progressive differentiation of TFR cells are intrinsically and extrinsically controlled by TFH programs
Follicular regulatory T (T<sub>FR</sub>) cells restrain follicular helper T (T<sub>FH</sub>) cell-mediated B cell responses to optimize humoral immunity while limiting autoimmunity. Here we assessed the developmental dynamics of T<sub>FR</sub> cells. We found that T<sub>FR</sub> cells undergo progressive differentiation through progenitor, early effector and late effector stages. Late effector T<sub>FR</sub> cells possessed inherent instability, and could lose expression of FoxP3 to become ExT<sub>FR</sub> cells. Expression of effector T<sub>FH</sub> programs in T<sub>FR</sub> cells preceded instability, a process that was mediated by Tcf7. A subset of ExT<sub>FR</sub> could be redeemed by re-expression of FoxP3. Extrinsically, T<sub>FH</sub> cells enhanced late effector T<sub>FR</sub> cell differentiation by diverting cells away from a default Prdm1/Blimp-1 fate to express Bcl6. Together, these data indicate that T<sub>FR</sub> cells are a dynamic and plastic cell subset, the differentiation of which is controlled by intrinsic and extrinsic programs that work together to form a feedback loop to control humoral immunity.
Authors
- Peter T. Sage (ORCID: https://orcid.org/0000-0002-7287-0326)
- Do H. Kim (ORCID: https://orcid.org/0000-0003-3389-2618)
- Kelly Burke
- Sierra Richardson
- Paulo Lisboa Raeder (ORCID: https://orcid.org/0000-0003-0604-3143)
- Manuel Alfredo Podestá
- Marcia C. Haigis (ORCID: https://orcid.org/0000-0003-2530-2681)
- Jonathan S. Bromberg (ORCID: https://orcid.org/0000-0002-1407-8795)
- Ridwan Bin Rashid (ORCID: https://orcid.org/0000-0001-5095-8848)
- Maya Gempler
- Samuel J. Gavzy
- Jeong-Mi Lee
- Cole Batty
- Arlene H. Sharpe
- Cyrus Yang
- Hengcheng Zhang
- Dejun Kong
- Pragya Chandrakar
Institutions
- University of Maryland, Baltimore (US)
- Brigham and Women's Hospital (US)
- Harvard University (US)
- Universidade de São Paulo (BR)
- Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico (IT)
- Massachusetts General Hospital (US)
- Boston VA Research Institute (US)
- Dana-Farber Cancer Institute (US)
- Io Therapeutics (United States) (US)
Publication Details
- Journal
- Nature Immunology
- Published
- 2026-01-13
- DOI
- https://doi.org/10.1038/s41590-025-02373-7
- Primary Topic
- T-cell and B-cell Immunology
- Type
- article
- Field-Weighted Citation Impact
- 0.00